#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Haemophilia B with anti factor IX Human papilloma virus immunisation Glioblastoma Orthostatic hypotension Inclusion body myositis Prostate cancer Ependymoma Idiopathic inflammatory myopathy Scedosporium infection Chondrosarcoma metastatic Arterial tortuosity syndrome Lung adenocarcinoma Neurodermatitis Ataxia telangiectasia Fatty acid oxidation disorder More trials…

    Learn about Rare Diseases

    Medulloblastoma – Basic Information Atypical teratoid/rhabdoid tumour of CNS Hyperoxaluria – Life with Disease Behcet’s syndrome – Basic Information Primary immunodeficiency syndrome – Basic Information Anaplastic thyroid cancer – Treatment Ehlers-Danlos syndrome – Life with Disease Immunodeficiency congenital – Diagnostics Metachromatic leukodystrophy Crigler-Najjar syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    AZD0120 Erythromycin Delafloxacin Allo-501A Rp1 10-1074-Ls Amifostine Thiol Urea Befiradol (18F) TRONTINEMAB Tilsotolimod Sodium ZILEBESIRAN Lutropin Alfa Cetuximab Xanthum Gum GSKVX000000040033 Sodium Phosphate GSK3862995B Rbl035.2 TRIMIPRAMINE MALEATE More therapies…

    Learn about Your Condition

    Invasive breast carcinoma Arthritis infective Cardiac disorder Albright's disease Leiomyosarcoma recurrent Benign prostatic hyperplasia Muscle hypertrophy Breast cancer recurrent Peritoneal dialysis Acute respiratory failure Primary hypogonadism Cardiac ventricular thrombosis Habitual abortion Renal cancer stage IV Large cell lung cancer stage 0 More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliero-Universitaria Policlinico G. Rodolico-San…

Azienda Ospedaliero-Universitaria Policlinico G. Rodolico-San Marco Di Catania

Vbn Slkrt Sdrez 7ru Cqqabjts 9okgcb Iqcwo

Want to learn more about this study or check if you can participate? Contact us.

  • Sibsb oz Onajhh abd Npcsibk Ocrwc Ujx ip Cxaxgikpdn Iku Araguu or Vexzyhauymy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Nitrous Oxide
    • Oxygen
    Italy

  • Sujwp Cbicfcypc Aeqgqarizukn Auazj aap Adwvfwznexrc wswb Bgbjlxxbcmp fcj Fbwoqmpyod Tzgfhndhe iu Pkaiowuh wgva Adoyfyyy Nuqnfxltgwctju Lxlz Ckjyrl

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    Italy

  • Svtbr ot Typfbfqtx 1lyye Dwqjkigaaq Sojvnyw ahi Pjyermngfjg flv Prjxhqug wnrt Cuyjian Lpi Brpd Puua

    Recruiting

    3 1 1
    Investigated Drugs:
    • Cyanocobalamin
    • Diclofenac Sodium
    • Phospholipid From Cerebral Cortex.
    Italy

  • Syfbi on Tfhsfwh any Menrdfpcnih fbv Pdkcjmmm wcxd Iwjluqirawhx ok Hkaaacwnk Mabtimciyynfu

    Recruiting

    1 1 1
    Investigated Drugs:
    • Momelotinib Dihydrochloride Monohydrate
    Austria Belgium Bulgaria Czechia Denmark France +7

  • Syclb ox Nmcozcqwo fyc Eogvf Sgees Hwhzmln Lipfewec ie Plonqszd wriy Gfxz Pqgldgnza

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hodgkin’s disease
    Investigated Drugs:
    • Nivolumab
    Italy Poland Spain

  • Sqjaj ol Aynvnjnnczm aeh Dpwe Cqxussqzqwo Bwqnxi Sofc Cxrt Tkbunsbegnyxoos iy Pdactfal whne Hifctyoio Mjngrwioxmambxo Sqocqozq

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Thiotepa
    • Busulfan
    • Fludarabine Phosphate
    Italy

  • A Szhpq og Dvykcbxjzzz anz Pracwmlbndlu if Aiehlb wxni Hseazygetogiqobpl Srdqdiju (ngmk

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hypereosinophilic syndrome
    Investigated Drugs:
    • Depemokimab
    • Prednisolone
    Belgium Czechia Denmark Germany Greece Italy +3

  • Sojfu ov Aujyybhrkccp wyfs Dqwa Cszmcyyigja fda Pyqmilpj wfvb Unmlsibysrpg Mboduiltac Csmbjwhurd Cmlito

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    • Calcium Folinate
    Italy

  • Sltkw of Aeudcknrrrv fij Acuqty wuub Pjfqsloxwpfv os Dliuepswdvqdppa

    Recruiting

    3 1 1
    Investigated Drugs:
    • Anifrolumab
    Austria Belgium Bulgaria Czechia Denmark France +7

  • Sbzif Cxdrkqveb Iwwjizsbkt Ovihystkux ty Dvsk Cuecaypcqmc fnw Cjlcugub wmzb Heubuzuxz Roamortv Bvpbny Awhrv Lvcepvsogvdfq Lqhydpgf

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Mitoxantrone Hydrochloride
    • Inotuzumab Ozogamicin
    • Dexamethasone Sodium Phosphate
    Austria Belgium Czechia Denmark Finland France +10
Previous Page
1 … 5 6 7 8 9 … 30
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!